Table 3.
Controls | Patients non-stenotic segments | Patients stenotic segments | P | ||||||
---|---|---|---|---|---|---|---|---|---|
N | % (median [IQR]) | N | % (median [IQR]) | N | % (median [IQR]) | Controls - patients non-stenotic segments | Controls - patients stenotic segments | Patients non-stenotic - stenotic segments | |
C2 | 18 | 25.7 [22.8–29.8] | 72 | 36.8 [33.4–40.9] | 0 | na | < 0.01 | na | na |
C3 | 18 | 34.0 [31.4–36.8] | 46 | 47.2 [42.4–51.8] | 26 | 70.8 [58.8–84.7] | < 0.01 | < 0.01 | < 0.01 |
C4 | 18 | 34.9 [32.6–36.7] | 34 | 51.7 [46.1–56.5] | 38 | 62.7 [53.7–81.0] | < 0.01 | < 0.01 | < 0.01 |
C5 | 18 | 35.6 [31.5–38.6] | 15 | 51.7 [39.8–55.2] | 57 | 72.5 [59.1–83.6] | 0.20 | < 0.01 | < 0.01 |
C6 | 18 | 29.2 [26.2–34.6] | 41 | 44.5 [35.2–51.3] | 29 | 66.2 [54.8–74.6] | < 0.01 | < 0.01 | < 0.01 |
C7 | 18 | 22.0 [20.9–25.5] | 17 | 32.2 [29.6–35.4] | 0 | na | < 0.01 | na | na |
N, number of measurements; IQR, interquartile range; na, not available. Significant findings are illustrated in bold letters.